Why Can’t One Gene Explain My Hair Loss Risk?

Bright, clean clinic waiting area in Japan with a reception desk, green plants, and soft indirect lighting

No single gene explains most male pattern hair loss because hundreds of common genetic differences each add a small amount of risk.

Together, those differences make the risk polygenic, and your family history can offer useful clues. A doctor can help you interpret your family history without waiting for one decisive test result.

Contents

Why one gene cannot explain your polygenic risk for hair loss

Polygenic means the risk is spread across many genes rather than set by one. A locus is simply a position in the genome where a genetic variant is located.

Common variants, not one rare switch

Most of the risk that runs in families comes from common gene variants that many people carry. A rare mutation can matter for a specific person, but it doesn’t explain the broad pattern across a population.

How the number of known gene regions rose

The count of associated loci has increased as studies included more men, and that growth points to a polygenic pattern.

A 2016 review named 12 associated regions; two 2017 studies found 63 and 71 loci; a 2018 analysis reported 624; and a 2025 review, counting in its own way, cited more than 380.1,2,3,4,5 Together, these findings reinforce the conclusion that risk is spread across many positions.

A growing list of reported loci

YearStudy scaleReported loci
2016Review of published evidence12 regions
2017Meta-analysis of eight cohorts63 loci
2017More than 70,000 men71 loci
2018205,327 men624 loci
2025Review of published evidenceMore than 380 loci

Counts rose because studies grew from thousands to hundreds of thousands of men and because the trait was polygenic all along, although reviews tally loci in different ways. Larger samples can detect more of the small signals that were already there.

Why a one-gene model does not fit families

Older single-gene ideas could not match the way male pattern hair loss appears in families. The condition is very common, varies in severity, and increases with each affected relative, which fits many small effects better than a single large-effect mutation.

Three patterns that point to many genes

  • A condition this common cannot rest on a rare single mutation.
  • The degree of thinning runs along a spectrum instead of forming clear yes-or-no categories.
  • Risk climbs as more relatives show hair loss.

These patterns do not follow a simple dominant rule where one inherited copy decides the outcome. Instead, many genetic variants contribute to the overall risk, influencing when hair loss begins and how severe it becomes.

What a polygenic hair loss risk score can and cannot tell you

A polygenic score adds many small genetic signals into one number. Heritability is the share of differences across a group that genes can explain, not a percentage assigned to one person.

What the numbers show

Among European men, 71 loci explained 38% of risk in a 2017 genome-wide study, and a 2018 analysis estimated heritability at 0.62 from close relatives and 0.39 from unrelated men.2,3,4

An early score split men into quarters, and the top quarter had about six times the odds of early-onset hair loss as the bottom quarter.6 These findings describe population-level risk and cannot reliably predict whether an individual will develop hair loss.

The difference between 0.62 and 0.39 reflects the methods used to measure heritability and the sources of variation each method captures. Estimates from close relatives can include shared family effects, while estimates from unrelated men count only the genetic differences measured in the study.

Limitations of polygenic risk scores

A 2013 score built in one half of a small German sample explained only 1.4 to 4.5% of variation in the other half.7 In 72,469 men, rare variants had a small role in population-level risk, while common variants carried most of the signal.8

Ancestry also shifts the picture: in African men, the X chromosome appears to matter less than it does in European men. A score can inform a discussion, but it does not replace an exam.

Family history is still a practical clue

Because the genetic signal is spread across many variants, your family history becomes a practical summary. You do not need a single named gene to report what you see.

Points to keep in mind

  • Treat early hair loss in several relatives as a broad signal, not a verdict.
  • Share information about both parents, brothers, and grandparents.
  • Connect that history with your current pattern and the age when thinning began.

Your family history will not point to a single gene. It reflects the combined influence of many genetic factors, and a doctor can compare it with your hair today.

Discussing your family history with a doctor can help put your current hair loss risk into context. Our doctors in Tokyo and Yokohama, Japan will examine your scalp and help you decide whether treatment is worth considering.

Frequently asked questions

Does finding many hair loss genes mean my risk is impossible to understand?

No. It means no single test result will decide your future, but your overall pattern can still guide a useful plan. A doctor can combine family history, timing, and a scalp exam to explain what may come next.

Should I still bring up my family history if no single gene explains baldness?

Yes. Family history remains one of the most practical clues because it reflects the combined influence of many genetic factors. List the relatives who had noticeable thinning and about when their hair loss began.

Does a high polygenic score mean I will definitely go bald?

No. A high score raises the odds for a group, but it doesn’t determine the outcome for one person. Your current pattern and a doctor’s exam matter more than a score alone.

What should I do next?

Start with a doctor visit if thinning is already visible or if your pattern worries you. Your doctor can consider your family history alongside your current hair loss pattern and suggest a clearer next step.

References

1. Heilmann-Heimbach, S., Hochfeld, L. M., Paus, R., & Nöthen, M. M. (2016). Hunting the genes in male-pattern alopecia: how important are they, how close are we and what will they tell us? Experimental Dermatology, 25(4), 251-7. https://doi.org/10.1111/exd.12965

2. Heilmann-Heimbach, S., Herold, C., Hochfeld, L. M., Hillmer, A. M., Nyholt, D. R., Hecker, J., Javed, A., Chew, E. G., Pechlivanis, S., Drichel, D., Heng, X. T., Del Rosario, R. C., Fier, H. L., Paus, R., Rueedi, R., Galesloot, T. E., Moebus, S., Anhalt, T., Prabhakar, S., … Nöthen, M. M. (2017). Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness. Nature Communications, 8, 14694. https://doi.org/10.1038/ncomms14694

3. Pirastu, N., Joshi, P. K., de Vries, P. S., Cornelis, M. C., McKeigue, P. M., Keum, N., Franceschini, N., Colombo, M., Giovannucci, E. L., Spiliopoulou, A., Franke, L., North, K. E., Kraft, P., Morrison, A. C., Esko, T., & Wilson, J. F. (2017). GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk. Nature Communications, 8(1), 1584. https://doi.org/10.1038/s41467-017-01490-8

4. Yap, C. X., Sidorenko, J., Wu, Y., Kemper, K. E., Yang, J., Wray, N. R., Robinson, M. R., & Visscher, P. M. (2018). Dissection of genetic variation and evidence for pleiotropy in male pattern baldness. Nature Communications, 9(1), 5407. https://doi.org/10.1038/s41467-018-07862-y

5. Liu, Y., Tosti, A., Wang, E. C. E., Heilmann-Heimbach, S., Aguh, C., Jimenez, F., Lin, S. J., Kwon, O., & Plikus, M. V. (2025). Androgenetic alopecia. Nature Reviews. Disease Primers, 11(1), 73. https://doi.org/10.1038/s41572-025-00656-9

6. Li, R., Brockschmidt, F. F., Kiefer, A. K., Stefansson, H., Nyholt, D. R., Song, K., Vermeulen, S. H., Kanoni, S., Glass, D., Medland, S. E., Dimitriou, M., Waterworth, D., Tung, J. Y., Geller, F., Heilmann, S., Hillmer, A. M., Bataille, V., Eigelshoven, S., Hanneken, S., … Richards, J. B. (2012). Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases. PLoS Genetics, 8(5), e1002746. https://doi.org/10.1371/journal.pgen.1002746

7. Heilmann, S., Brockschmidt, F. F., Hillmer, A. M., Hanneken, S., Eigelshoven, S., Ludwig, K. U., Herold, C., Mangold, E., Becker, T., Kruse, R., Knapp, M., & Nöthen, M. M. (2013). Evidence for a polygenic contribution to androgenetic alopecia. The British Journal of Dermatology, 169(4), 927-30. https://doi.org/10.1111/bjd.12443

8. Henne, S. K., Aldisi, R., Sivalingam, S., Hochfeld, L. M., Borisov, O., Krawitz, P. M., Maj, C., Nöthen, M. M., & Heilmann-Heimbach, S. (2023). Analysis of 72,469 UK Biobank exomes links rare variants to male-pattern hair loss. Nature Communications, 14(1), 5492. https://doi.org/10.1038/s41467-023-41186-w

Share this article
  • URL copied!
  • URL copied!
Contents